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Zimbabwe’s COVID-
19 vaccination roll-out: 
Urgent need to rethink 
strategies to improve the 
supply chain
To the Editor: As of 26 June 2021, Zimbabwe 
had 46 018 confirmed COVID-19 cases, 
including 37 761 recoveries and 1 725 
deaths, and a total of 747 330 people had 
been vaccinated against COVID-19. [1] The 
country is currently facing a third wave of 
COVID-19, with hospital beds approaching 
maximum capacity and the oxygen supply 
running out fast with no clear plans for 
replenishments. The rollout of a COVID-19 
vaccine programme presented a glimmer of 
hope for the country to control the pandemic 
and end restrictions. However, at present, 
inadequate vaccine supply[2] and vaccine 
hesitancy[3] persist as major threats to rapidly 
achieving herd immunity. 
At present, Zimbabwe has authorised the 
use of Chinese vaccines from Sinopharm and 
Sinovac, Sputnik V from Russia, and Covaxin 
from India. No vaccines produced in Western 
countries have been registered for use in the 
country. The government recently turned 
down a donation of three million doses of 
the Johnson & Johnson COVID-19 vaccine, 
citing the lack of infrastructure to deal 
with the refrigeration requirements of the 
vaccine. [4] Zimbabwe will fail to make much 
use of the vaccines that need to be refrigerated 
at very low temperatures owing to lack of 
equipment. There are unverified reports of 
imminent registration of a three-jab vaccine 
from Cuba, results for which have recently 
been made public. Further, indications are 
that the more affluent individuals in the 
country’s two largest cities, Harare and 
Bulawayo, have received a larger percentage 
of vaccines compared with the rural areas 
where nearly 70% of the population reside.[2]
We show the trend of COVID-19 cases and 
vaccination doses given during the period 
February - June 2021 in Fig. 1. 
With an estimated population of ~15 
million, Zimbabwe requires a rethink 
around increasing the current vaccination 
numbers, which are >1 million despite 4 
months having elapsed since the initial 
rollout of the COVID-19 vaccination 
programme. 
For Zimbabwe to rapidly achieve herd 
immunity, it must immediately join the 
COVAX facility to improve its vaccine 
supply chain and in turn increase the 
number of doses available to its people, and 
deal decisively and creatively with vaccine 
hesitancy. In the interim, Zimbabwe will 
need to depend more on lockdown restric-
tions and enforcement of other non-
pharmaceutical interventions, including 
social distancing, to try to contain the 
aggressive third wave currently sweeping 
through southern Africa, leaving significant 
morbidity and mortality in its path. 
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Fig. 1. COVID-19 cases and vaccine doses in Zimbabwe. 
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Fig. 1. COVID-19 cases and vaccine doses in Zimbabwe.
